Evaluation of Nontargeted Mass Spectral Data Acquisition Strategies for Water Analysis and Toxicity-Based Feature Prioritization by MS2Tox
Environmental Science & Technology · 2024
DOI: 10.1021/acs.est.4c02833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Science & Technology, 2024. Verfasst von Pilleriin Peets und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials and Environmental Chemistry, Stockholm University, Svante Arrhenius Väg 16, SE-106 91, Stockholm, Sweden. Hauptthemen laut MEDLINE: Water Pollutants, Chemical. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Svenska Forskningsr??det Formas, Deutsche Forschungsgemeinschaft, Stiftelsen f??r Milj??strategisk Forskning.
Abstract (Originalsprache)
The machine-learning tool MS2Tox can prioritize hazardous nontargeted molecular features in environmental waters, by predicting acute fish lethality of unknown molecules based on their MS2 spectra, prior to structural annotation. It has yet to be investigated how the extent of molecular coverage, MS2 spectra quality, and toxicity prediction confidence depend on sample complexity and MS2 data acquisition strategies. We compared two common nontargeted MS2 acquisition strategies with liquid chromatography high-resolution mass spectrometry for structural annotation accuracy by SIRIUS+CSI:FingerID and MS2Tox toxicity prediction of 191 reference chemicals spiked to LC-MS water, groundwater, surface water, and wastewater. Data-dependent acquisition (DDA) resulted in higher rates (19-62%) of correct structural annotations among reference chemicals in all matrices except wastewaters, compared to data-independent acquisition (DIA, 19-50%). However, DIA resulted in higher MS2 detection rates (59-84% DIA, 37-82% DDA), leading to higher true positive rates for spectral library matching, 40-73% compared to 34-72%. DDA resulted in higher MS2Tox toxicity prediction accuracy than DIA, with root-mean-square errors of 0.62 and 0.71 log-mM, respectively. Given the importance of MS2 spectral quality, we introduce a "CombinedConfidence" score to convey relative confidence in MS2Tox predictions and apply this approach to prioritize potentially ecotoxic nontargeted features in environmental waters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Materials and Environmental Chemistry, Stockholm University, Svante Arrhenius Väg 16, SE-106 91, Stockholm, Sweden.
- Institute of Biodiversity, Faculty of Biological Science, Cluster of Excellence Balance of the Microverse, Friedrich-Schiller-University Jena, 07743, Jena, Germany.
- Department of Environmental Science, Stockholm University, Svante Arrhenius Väg 16, SE-106 91 Stockholm, Sweden.
- National Facility for Exposomics, Metabolomics Platform, Science for Life Laboratory, Stockholm University, Solna 171 65, Sweden.
ORCID-Profile: Pilleriin Peets, May Britt Rian, Jonathan W Martin, Anneli Kruve
Förderung
- Svenska Forskningsr??det Formas
- Deutsche Forschungsgemeinschaft
- Stiftelsen f??r Milj??strategisk Forskning
Zitieren
APA
Peets, P., Rian, M. B., Martin, J. W., & Kruve, A. (2024). Evaluation of Nontargeted Mass Spectral Data Acquisition Strategies for Water Analysis and Toxicity-Based Feature Prioritization by MS2Tox. Environmental Science & Technology. https://doi.org/10.1021/acs.est.4c02833
Vancouver
Peets P, Rian MB, Martin JW, Kruve A. Evaluation of Nontargeted Mass Spectral Data Acquisition Strategies for Water Analysis and Toxicity-Based Feature Prioritization by MS2Tox. Environmental Science & Technology. 2024. doi:10.1021/acs.est.4c02833
BibTeX
@article{Peets2024,
author = {Peets, Pilleriin and Rian, May Britt and Martin, Jonathan W and Kruve, Anneli},
title = {Evaluation of Nontargeted Mass Spectral Data Acquisition Strategies for Water Analysis and Toxicity-Based Feature Prioritization by MS2Tox},
journal = {Environmental Science & Technology},
year = {2024},
doi = {10.1021/acs.est.4c02833}
}
EUVIMED